KINIKSA PHARMACEUTICALS LTD shareholders Q3 2023

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 139 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

KINIKSA PHARMACEUTICALS LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Legato Capital Management LLC 66,918$1,162,3660.17%
ArrowMark Colorado Holdings LLC 760,353$13,207,3320.16%
Nebula Research & Development LLC 13,686$237,7260.12%
DRIEHAUS CAPITAL MANAGEMENT LLC 503,750$8,750,1380.11%
GSA CAPITAL PARTNERS LLP 63,216$1,0980.09%
DARK FOREST CAPITAL MANAGEMENT LP 65,029$1,129,5540.09%
Campbell & CO Investment Adviser LLC 31,895$554,0160.07%
Hennion & Walsh Asset Management, Inc. 55,047$956,1660.06%
PERSONAL CFO SOLUTIONS, LLC 14,238$247,3140.05%
UBS OCONNOR LLC 106,423$1,848,5680.05%
Hudson Bay Capital Management LP 605,000$10,508,8500.04%
Pictet Asset Management Holding SA 1,604,717$27,873,9340.03%
Trexquant Investment LP 76,823$1,334,4160.03%
WINTON GROUP Ltd 22,504$390,8940.03%
Schonfeld Strategic Advisors LLC 208,500$3,621,6450.03%
Caption Management, LLC 90,000$1,563,3000.02%
PROFUND ADVISORS LLC 23,506$408,2990.02%
Connor, Clark & Lunn Investment Management Ltd. 256,932$4,462,9090.02%
Vestcor Inc 34,434$5980.02%
Caption Management, LLC 80,000$1,389,6000.02%
External links

This page lists KINIKSA PHARMACEUTICALS LTD's shareholders in Q3 2023. To view KINIKSA PHARMACEUTICALS LTD's shareholder history, click here.